How fast does ahcc work. AHCC Supplementation Shows Promise in Clearing Persistent HPV Infections: Phase II Trial Results
How does AHCC impact persistent HPV infections. What are the key findings of the phase II trial on AHCC supplementation. How effective is AHCC in clearing high-risk HPV infections. What implications does this study have for HPV-related cancer prevention.
Understanding Persistent HPV Infections and Their Cancer Risk
Human Papillomavirus (HPV) infections are a significant concern for many individuals due to their potential to develop into cancer. While most HPV infections clear naturally within two years, about 10% persist for longer periods, increasing the risk of abnormal cell formation and potential cancer development. These persistent infections, lasting more than two years, are particularly worrisome for those with high-risk HPV strains.
Why are persistent HPV infections problematic? The longer an HPV infection remains active in the body, the higher the likelihood of abnormal cancer cells forming. This prolonged presence of the virus allows it more time to potentially damage cellular DNA and trigger the process of carcinogenesis.
Factors Influencing HPV Persistence
Several factors can contribute to the persistence of HPV infections:
- Weakened immune system
- Poor diet
- Insufficient sleep
- Chronic stress
- Advanced age
These factors can compromise the body’s natural ability to clear the virus, leading to prolonged infections and increased cancer risk. Understanding these risk factors is crucial for developing effective prevention and treatment strategies.
Current Treatment Approaches for Persistent HPV Infections
At present, there is no systemic treatment available for persistent HPV infections. The current medical approach relies heavily on early detection and localized treatments. What are the common treatment modalities for HPV-related lesions?
- Cryotherapy
- Surgical excision
- Loop electrosurgical excisional procedure (LEEP)
- Cold knife conization
While these treatments boast a high response rate of approximately 80%, patients frequently experience recurrent lesions. This recurrence highlights the need for more effective, long-term solutions to address persistent HPV infections.
Moreover, screening and treatment protocols for HPV infections in areas other than the cervix, such as the anus, are still in their infancy. The Anchor Study has demonstrated that screening for HPV and treating precancerous cells can reduce the incidence of anal cancer. However, this type of screening is currently limited in availability and not yet widely implemented.
AHCC: A Promising Supplement for HPV Clearance
AHCC (Active Hexose Correlated Compound) has emerged as a potential game-changer in the fight against persistent HPV infections. But what exactly is AHCC? It’s a proprietary, standardized extract derived from cultured lentinula edodes mycelia, known for its unique immune-modulating properties.
Research on AHCC has revealed a variety of therapeutic effects, including:
- Enhanced antioxidant activity
- Anticancer properties
- Modulation of the immune system
- Prevention of viral and bacterial infectious processes
These properties make AHCC a promising candidate for supporting the immune system in clearing persistent HPV infections.
Pilot Studies: Early Evidence of AHCC Efficacy
Two pilot studies provided the initial evidence for AHCC’s potential in clearing persistent HPV infections:
- In the first study, 50% of women (4 out of 8) with persistent HPV infections cleared their infection within 3 to 6 months of taking 3g of AHCC daily on an empty stomach.
- The second study, using a lower dose of 1g AHCC daily, showed a similar response rate of 44% (4 out of 9 women) clearing high-risk HPV persistent infections after 7 months of supplementation.
These promising results paved the way for a more comprehensive phase II trial to further investigate AHCC’s efficacy in clearing persistent HPV infections.
Phase II Trial: AHCC Supplementation for Persistent HPV Infections
The phase II trial, conducted by Dr. Judith Smith and approved by the University of Texas Health Sciences Center Institutional Review Board, aimed to determine the efficacy, safety, and durability of AHCC supplementation in clearing high-risk HPV infections. How was the study designed?
- Randomized, double-blind, placebo-controlled study
- 50 women over age 30 with persistent HPV infections (lasting more than two years)
- 12-month study duration
- Two groups: AHCC supplementation (3g daily for 6 months) followed by placebo, and a control group receiving only placebo
- Evaluations every 3 months using HPV-DNA and HPV-RNA testing
- Blood samples analyzed for immune markers, including interferon-alpha, interferon-beta, interferon-gamma, IgG1, T-lymphocytes, and natural killer cell levels
Key Findings of the Phase II AHCC Trial
The results of the phase II trial provide compelling evidence for the efficacy of AHCC in clearing persistent HPV infections. What were the main outcomes of the study?
Of the 41 women who completed the study:
- 63.6% (14 out of 22) in the AHCC group showed clearance of their HPV infection
- The placebo group showed no significant clearance of HPV infections
This 58% effectiveness rate in clearing persistent HPV infections is a significant finding, offering hope to those struggling with long-term HPV infections and their associated cancer risks.
Immune System Impact
The study also revealed interesting changes in immune markers among participants taking AHCC. How did AHCC supplementation affect the immune system?
- Increased natural killer (NK) cell activity
- Enhanced T cell and B cell proliferation
- Elevated interferon-gamma levels
These immune system changes suggest that AHCC may work by boosting the body’s natural defenses against viral infections, potentially explaining its efficacy in clearing persistent HPV.
Implications for HPV-Related Cancer Prevention
The findings of this phase II trial have significant implications for the prevention of HPV-related cancers. By potentially clearing persistent HPV infections, AHCC supplementation could help reduce the risk of developing cervical, anal, and other HPV-associated cancers.
How might AHCC supplementation impact current HPV management strategies?
- Potentially reduce the need for invasive treatments like LEEP or conization
- Offer a systemic approach to managing HPV infections in various body sites
- Provide a complementary strategy to existing screening and treatment protocols
- Offer hope for those with recurrent HPV infections or lesions
While more research is needed to fully understand the long-term benefits and optimal use of AHCC for HPV clearance, these initial results are highly promising.
Safety and Tolerability of AHCC Supplementation
An important aspect of any potential treatment is its safety profile. How well was AHCC tolerated by study participants?
The phase II trial reported no significant adverse events related to AHCC supplementation. Participants generally tolerated the 3g daily dose well, with minimal side effects reported. This favorable safety profile adds to the potential of AHCC as a viable option for managing persistent HPV infections.
Common mild side effects reported in some studies of AHCC include:
- Mild gastrointestinal discomfort
- Headaches
- Fatigue
However, these effects were typically transient and did not lead to discontinuation of the supplement in most cases.
Future Directions in AHCC Research for HPV Management
While the results of this phase II trial are encouraging, they also open up new avenues for further research. What are some potential areas for future investigation?
- Larger-scale clinical trials to confirm efficacy and safety
- Studies on optimal dosing and duration of AHCC supplementation
- Investigation of AHCC’s effects on different HPV strains
- Research on combining AHCC with other treatments or preventive strategies
- Long-term follow-up studies to assess the durability of HPV clearance
Additionally, research into the precise mechanisms by which AHCC modulates the immune system to clear HPV infections could provide valuable insights for developing other immunomodulatory treatments.
Potential Applications Beyond HPV
Given AHCC’s immune-modulating properties, could it have applications beyond HPV management? Some areas of potential interest include:
- Other viral infections
- Cancer prevention and supportive care
- Immune system support in immunocompromised individuals
These possibilities highlight the need for continued research into the broad spectrum of AHCC’s potential health benefits.
Practical Considerations for AHCC Supplementation
For individuals considering AHCC supplementation based on these promising results, several practical aspects should be considered. How should one approach AHCC supplementation?
- Consult with a healthcare provider before starting any new supplement regimen
- Follow recommended dosages based on clinical studies (typically 3g daily)
- Take AHCC on an empty stomach for optimal absorption
- Be patient, as effects may take several months to manifest
- Continue regular HPV screenings and follow-ups as recommended by your healthcare provider
It’s important to note that while AHCC shows promise, it should not be considered a replacement for standard medical care or HPV vaccination. Rather, it may serve as a complementary approach to supporting immune function and potentially clearing persistent HPV infections.
Cost and Availability
AHCC supplements are available over the counter, but their cost can be a consideration for long-term use. Prices vary depending on brand and dosage, and insurance typically does not cover supplement costs. Individuals interested in AHCC supplementation should factor in these financial considerations when making their decision.
In conclusion, the phase II trial results for AHCC supplementation in clearing persistent HPV infections offer a ray of hope for those dealing with long-term HPV and its associated cancer risks. With a 58% effectiveness rate and a favorable safety profile, AHCC presents a promising avenue for supporting the immune system in combating persistent HPV infections. As research continues, AHCC may become an important tool in the comprehensive management of HPV and the prevention of HPV-related cancers. However, it’s crucial to approach this supplement with informed caution, always in consultation with healthcare professionals and as part of a broader health strategy.
AHCC Clears HPV Infections in Phase II Trial
People who have high-risk HPV fear getting cancer, but don’t know how to prevent it. The only advice doctors can provide is to support the immune system by eating well, sleeping well, and reducing stress. In support groups, survivors of HPV cancers express great fear that their HPV will lead to cancer yet again. So, for people who have high-risk HPV, any research on a supplement that supports the immune system’s ability to clear persistent HPV infections is profoundly significant. This new phase II study showing that AHCC is 58% effective at clearing persistent HPV infections provides hope for those of us who have high-risk HPV.
A persistent HPV infection is defined as one that lasts for more than two years, and the longer an HPV infection is active, the more likely it is that abnormal cancer cells will form. Although most people clear HPV infections naturally in 2 years if their immune system is strong, not everyone has a strong immune system. The immune system can be compromised by poor diet, insufficient sleep, stress, or just age. About 10% of people with HPV infections have persistent infections that last for more than 2 years. Since persistent high-risk HPV infections are the most likely to cause cancer, it is important to study these cases.
To date, there is no systemic treatment for persistent HPV infections. Current treatment modalities rely on early detection in vaginal PAP smears followed by treatments like cryotherapy, surgical excision, loop electrosurgical excisional procedure (LEEP), or cold knife conization. Although these treatments have a high response rate of 80%, patients will frequently have recurrent lesions. In addition, there is not yet an established medical protocol for screening and treating HPV infections in other parts of the body, like the anus. The Anchor Study, for example, has shown that screening for HPV and treating precancerous cells can lower the incidence of anal cancer. But this type of screening is in its infancy and only available in select locations. It would therefore be better to prevent these cell changes from happening in the first place. This phase II study of AHCC supplementation provides hope that persistent HPV infections can be prevented from progressing to cancer.
What Is AHCC?
The AHCC supplement is a proprietary, standardized extract of cultured lentinula edodes mycelia that has been shown to have unique immune modulatory benefits. Several animal and human studies have reported a variety of therapeutic effects, including enhanced antioxidant effects, anticancer activity, and modulation of the immune system to prevent the infectious processes of both viral and bacterial infections. This new clinical trial suggests that AHCC can also help the immune system clear persistent HPV infections.
Pilot Studies of AHCC to Clear HPV Infections
AHCC originally showed promise in two pilot studies. In one study of women with persistent HPV infections, 4 out of the 8 women who remained in the study (50%) cleared their persistent HPV infection between 3 to 6 months after starting a 3g daily dose of AHCC on an empty stomach. In a second pilot study, women were given 1g of AHCC a day on an empty stomach and showed a similar response rate: 4 out of the 9 women (44%) confirmed clearance of high-risk HPV persistent infections after 7 months of supplementation. These pilot studies provided the rationale to move forward with a phase II trial of AHCC to clear persistent HPV infections.
The New Phase II Study
Our medical advisory board member Judith Smith conducted this phase II randomized, double-blind, placebo-controlled study with a post unblinded study. This trial was reviewed and approved by the University of Texas Health Sciences Center Institutional Review Board. The objective of the study was to determine the efficacy, safety, and durability of AHCC supplementation for 6 months to support the host immune system to clear high-risk HPV infections.
Fifty women over age 30 with persistent HPV infections that had lasted more than two years were studied for 12 months. Patients were randomized into two groups: one group took AHCC 3g by mouth once daily on an empty stomach for six months followed by a placebo for the remaining 6 months. The control group was given a placebo. Every 3 months patients were evaluated with HPV-DNA and HPV-RNA testing and with a blood sample to evaluate a panel of immune markers including: interferon‐alpha(INN), interferon‐beta (IFNβ), interferon‐gamma (IFN), IgG1, T‐lymphocytes, and natural killer(NK) cell levels.
Of the 41 women who completed the study, fourteen (63.6%) of the 22 patients in the AHCC supplementation arm were HPV-RNA/HPV-DNA negative after six months, and 64.3% (9/14) achieved a durable response defined as also being HPV-RNA/HPV-DNA negative 12 months after the supplementation ended. In contrast, in the placebo arm of the study, only two (10.5%) of 19 patients were HPV negative at 12 months. An additional twelve patients completed the un-blinded study and 50% were HPV-RNA/HPV-DNA negative after six months of AHCC supplementation.
Combining all 34 participants that received AHCC supplementation gives an overall response rate of 58.8% that cleared HPV persistent infections.
Conclusions
Results from this phase II study demonstrated that AHCC 3g once daily on an empty stomach was effective in supporting the host immune system’s elimination of persistent HPV infections and was well tolerated with no significant adverse side effects reported.
Directions for Further Research
An additional finding of the study was that suppression of IFNβ to less than 20pg/mL correlated with an increase in T‐lymphocytes and IFN and durable clearance of HPV infections in women that received AHCC supplementation. This merits further evaluation as a clinical tool for monitoring patients with HPV infections. The duration of AHCC supplementation required beyond first negative result also needs more evaluation to optimize success for durable outcomes.
AHCC is Unique
It’s important to distinguish AHCC from other medicinal mushrooms. AHCC is the only medicinal mushroom that has been clinically demonstrated to help eradicate HPV. It is not interchangeable with other medicinal mushrooms because it has been specially developed and processed to maximize its immune-boosting capacity. AHCC is made by cell culturing a specific subspecies of mushroom identified by Japanese scientists several decades ago to have the greatest ability to increase natural killer cell activity. Its molecular weight has been reduced using a patented enzymatic process to improve its absorption and clinical efficacy. Every batch of AHCC is subjected to DNA pattern testing to confirm its identity (in other words, to ensure it is genuine AHCC). These innovations make AHCC unique among medicinal mushrooms.
AHCC is available from multiple nutritional supplement companies, but it is important to steer clear of fake products using different names yet claiming similar benefits. Only genuine AHCC® has been clinically tested and found to help clear HPV.
Click to read the full study
Here is a list of genuine AHCC products.
AHCC® is a registered trademark of the Amino Up Company
A Note for Anal Cancer Survivors
Because this study was conducted on women with vaginal HPV infections, we reached out to Dr. Romesser, a radiation oncologist specializing in anal cancer at Memorial Sloan Kettering, to ask about anal cancer survivors and AHCC. No side effects from AHCC were reported in women with vaginal HPV in the study described above; however, there is some anecdotal indication that there may be mild side effects for anal cancer survivors. Dr. Romesser has noticed that some anal cancer survivors experience side effects like anal itching when they start taking AHCC. Therefore, he recommends that anal cancer patients who have recently had treatment, wait to take AHCC until all the side effects from treatment have subsided. It also seems that for some anal cancer survivors, the side effects from taking AHCC go away after a few weeks. It might be worthwhile to continue taking AHCC for a few weeks despite any side effects in case the side effects subside.
Can AHCC Cure HPV & How Much Should I Take?
The human papillomavirus, otherwise known as HPV, is a common virus that contributes to an estimated 630,000 new cancer cases annually worldwide (1). Cancer of the cervix represents over 80 percent of the cases caused by the virus. According to the CDC, other types of cancers have been attributed to HPV, such as 70 percent of oropharyngeal cancer, 90 percent of anal cancer, and 70 percent of vaginal and vulvar cancer (2). There are 100 different types of HPV, many of which do not cause cancer. However, researchers have identified 6 HPV types as definite human carcinogens (3).
Is there any way to help get rid of HPV infections? Read on to learn more about how HPV affects the body and why a supplement called AHCC may be able to help.
Do HPV Infections Go Away?
HPV often disappears from Pap test results within about two years, often without any treatment. While this scenario happens in the majority of cases, it does not always occur that way.
In some instances of HPV infections, the virus stays dormant and surfaces many years later. In these cases, the infections never really get resolved, and HPV ends up lingering for a long time. The body has a particularly hard time responding to the virus in people with weakened immune systems. When the infection persists, the potential for more serious complications increases, leading to the incidence of cervical cancer, genital warts, and other issues.
What’s the Most Effective Approach to Treat HPV?
Optimal immune function is essential to defend against pathogenic invaders like HPV. While there is no known cure for HPV infections, strengthening the immune system with natural substances such as AHCC has shown promising results.
AHCC is a cultured extract of various species of medicinal mushroom mycelia (roots). It has an immune-boosting effect that enables it to assist the body in eradicating the virus. This extract enhances immune function by increasing the number and activity of natural killer cells and other immune cells.
Over 30 human clinical trials looked at the effectiveness of AHCC in the treatment of many severe conditions, such as head and neck cancer, liver cancer, and HPV-positive cervical cancer. The results of these studies have been so impressive that some of the most prestigious institutions around the world have studied AHCC.
A pilot study at the University of Texas Health Science Center at Houston followed 10 HPV-positive women who took 3 grams of AHCC once daily for three months, and up to six months. At the end of the trial, 50% of the women tested negative for HPV (4). These are incredibly encouraging results considering that there is currently no cure for the condition.
What Dosage of AHCC Should I Take to Eradicate HPV?
Based on the best available scientific evidence, 3 grams of HPV cure AHCC. Daily AHCC appears to be an effective AHCC HPV dosage for the eradication of HPV. Treatment with this supplement makes the virus dormant in the body, so to achieve continuous suppression, it is important to continue taking the supplement indefinitely.
Editor’s pick: Active Hexose Correlated Compound by HPD Rx This supplement is clinically tested and made from the highest quality ingredients.
Sources
- Worldwide burden of cancer attributable to HPV by site, country and HPV type: National Institutes of Health, 2017.
- HPV-Associated Cancer Statistics: Centers for Disease Control and Prevention, 2018.
- Global burden of human papillomavirus and related diseases: National Institutes of Health, 2012.
- Mushroom extract, AHCC, helpful in treating HPV: ScienceDaily, 2014.
AHCC / Active Hemicellulose NOW
AHCC / Active Hemicellulose NOW – A mixture of various biologically active substances (amino acids, polysaccharides, minerals and other biologically active substances) – support of the immune system.
ANSS – revolutionary discovery of Japanese scientists .
Active Hemicellulose Compound, 500mg 60 capsules.
A mixture of various biologically active substances (amino acids, polysaccharides, minerals and other biologically active substances) with a molecular weight of 500 – 1,000,000 daltons.
About 70% of is high molecular weight polysaccharides.
About 20% of are small polysaccharides (oligosaccharides) with a molecular weight of 3000-5000 daltons – alpha-1-4-glucans and their esterified hydroxyl forms.
In addition, AHCC contains a small fraction of beta-glucans.
The unique component of AHCC is a GI saccharide with a molecular weight of 1,000.
AHCC is an abbreviation of English words (Active Hemi-Cellulose Compound). AHCC technology – was developed by the Japanese company Amino UP Chemical Co. Ltd. (Sapporo) and Dr. Toshihiko Okamoto from the Faculty of Pharmacology, University of Tokyo in 1989.
The process is as follows. A hybrid of shiitake, maitake and reishi grown in a liquid nutrient medium based on brown rice. The shell of rice grains is rich in cellulose. Shiitake, maitake, and reishi mushrooms lack chlorophyll and, unlike plants, are not capable of photosynthesis. So they eat like animals. They release enzymes into the environment, digest the nutrients there, and absorb them. During this process, rice cellulose, a high molecular weight polysaccharide, is broken down by fungal enzymes (carbohydrases) into small fragments – oligosaccharides.
After a certain period of cultivation mushroom material with fermentation products is centrifuged, concentrated and subjected to dry freezing. Then it is packaged in capsules .
Shiitake Mushroom (Shiitake – Lentinula edodes) Since the 1960s, shiitake has been subjected to intensive scientific research. Eating 9g dried shiitake mushroom (equivalent to 90g fresh) for 7 days has been shown to lower cholesterol levels in 40 elderly people by 15% and in 420 young women by 15%. In 1969, researchers at the National Research Center in Tokyo isolated the polysaccharide lentinan from shiitake.
By now it is a well-known pharmacological preparation for intravenous administration in disorders of the immune system and oncological diseases .
In the 1970s, Japan mastered the technology for obtaining LEM (Lentinula edodes myucelium) – an extract from shiitake mycelium. In the 80s, in 16 clinics in Japan, 40 patients with hepatitis B received 6 g of LEM daily for 4 months. All patients experienced significant relief, and in 15 the virus was completely inactivated. LEM has been shown to be highly effective in HIV infection. In its ability to curb the development of AIDS, it surpassed such a well-known drug as AZT (laboratory studies with T4 helper cells).
Maitake mushroom (Maitake – Grifola frondosa)
In Japan, Maitake is called the dancing mushroom for its bizarre shape. It is well known for its ability to lower blood pressure and normalize blood lipids. But the true fame of maitake brought anti-cancer properties. Two polysaccharides were identified in its composition: grifolan and D-fraction. Grifolan activates macrophages. D-fraction enhances cellular immune responses. One study, which included 165 cancer patients, showed the effectiveness of the D-fraction, especially in leukemia and gastric cancer. Another high molecular weight maitake polysaccharide, X-fraction, has been shown in laboratory studies in mice to normalize blood sugar levels and insulin sensitivity in type II diabetes.
Reishi Mushroom (Reishi – Ganoderma lucidum) For 4,000 years, Reishi mushroom has been used by the Chinese and later by the Japanese for liver disease, high blood pressure and joint inflammation. Modern laboratory and clinical studies have revealed the anti-inflammatory, antiviral, antimicrobial, antiallergic and antitumor properties of reishi mushroom.
Reishi mushroom has a special therapeutic value in diseases of the upper respiratory tract . In one study, 2,000 Chinese people with chronic bronchitis took reishi syrup for 2 weeks. 60-90% of them noted a pronounced improvement in well-being. But the almost mystical property of Reishi is its ability to increase the strength of the spirit, increase a positive emotional mood.
Effect of ANCC polysaccharides on receptors:
1. The effect of AHCC polysaccharides on receptors and their absorption by macrophages leads to the fact that macrophages:
– activate T-helpers;
– they secrete interleukin-12, which directs the development of T-helpers to provide the cellular link of immunity, and also dramatically increases the activity of natural killers, the main fighters against tumor cells.
– secrete other cytokines: interleukins 1, 6, tumor necrosis factor alpha, which enhances inflammatory reactions and integrates the protective reactions of the whole organism.
2. Activated T-helpers:
– they begin to secrete interleukin-2, which leads to the reproduction and activation of T-helpers, as well as T-killers, macrophages and natural killers, which increase their cytotoxicity in relation to tumors.
– act on macrophages with interferon-gamma and tumor necrosis factor-alpha, as a result of which macrophages acquire antitumor properties (the ability to process tumor antigens, release of tumor necrosis factors alpha and beta, direct destruction of tumor cells, etc. )
– with the help of interleukin-3 and colony-stimulating factors, they increase the processes of hematopoiesis. There is every reason to believe that the low molecular weight components of AHCC have a direct mitogenic (stimulating reproduction) effect on T-helpers.
3. Activated natural killers dramatically increase their antitumor effect and secrete interferon-gamma, which activates macrophages. It can also be assumed that low molecular weight components have a direct stimulating effect on natural killers.
4 . Direct antitumor effect AHCC . Some components of AHCC have a direct antitumor effect by inhibiting tumor growth and neutralizing tumor factors that suppress the immune system (such as transforming growth factor-beta). The onset of the tumor process occurs when the immune system is weakened. Most tumors, due to the fact that they originate from the body’s own tissues, have a weak immunogenicity. Malignant growth is always accompanied by a significant weakening of immune functions. The number of type 1 T-helpers, which are the organizers of the immune response from the cellular link of immunity, is especially sharply reduced. Namely, T-killers, natural killers, K-cells, macrophages play a major role in antitumor immunity. In addition, the immune system is drastically weakened after surgery, radiotherapy and chemotherapy.
5. AHCC liver protection . ANSS has a pronounced protective effect on the liver, which is important not only in the treatment of hepatitis, but also provides the general ability of the body to detoxify, as well as providing it with various biomolecules, the synthesis of which occurs in the liver.
6. Antioxidant effect of AHCC.
ANSS has a pronounced antioxidant effect, which is important in the complex therapy of malignant diseases, rehabilitation after radio- and chemotherapy.
Indications for use:
– Benign and malignant neoplasms.
– Immunodeficiency.
– Hepatitis B and C.
– Diabetes.
– Herpes.
– Skin viral diseases.
– Atopic dermatitis.
– Chronic fatigue syndrome.
How to use:
Doses recommended by the Association for the Study of AHCC.
1. Disease prevention doses: AHCC 1000-3000 mg or 2-6 capsules daily in three divided doses.
Children for prevention – 1 capsule 1 time per day.
2. Support in the treatment of cancer, prevention of side effects of anti-cancer therapy: 3000-6000 mg AHCC or 6-12 capsules per day. The Association for the Study of AHCC recommends that AHCC support the immune system in all types of cancer except blood disorders.
Course duration: 2 weeks to improve the quality of life (especially after radio- and chemotherapy). 3 months to reassess the severity of cancer.
Children’s dose = (adult dose / 75) x child’s weight.
Discount on AHCC – Joy of body and soul – LJ
Now a 10% discount on AHCC, I’ll tell you briefly about what I drink – what it is and how it affects me.
I’m halfway through the second can now, and although the intake of such a drug should be longer, I’ll report now because of the discount. The drug is expensive and 10% if you buy several jars can be a significant savings.
I drink at the maximum dose shown on the site 750mg per capsule (250mg and 500mg are available). Take 2 capsules in the morning on an empty stomach with a glass of water.
AHCC is an abbreviation of the English words (Active Hemi-Cellulose Compound) (Active Hexose Correlation Complex).
Produced from medicinal mushrooms by a proprietary mushroom mycelium culturing process. clinical efficacy.
AHCC Technology – was developed by the Japanese company Amino UP Chemical Co. Ltd. (Sapporo) and Dr. Toshihiko Okamoto from the Faculty of Pharmacology, University of Tokyo in 1989. The process looks like this. A hybrid of shiitake, maitake and reishi is grown in a liquid nutrient medium based on brown rice. The shell of rice grains is rich in cellulose. Shiitake, maitake, and reishi mushrooms lack chlorophyll and, unlike plants, are not capable of photosynthesis. So they eat like animals. They release enzymes into the environment, digest the nutrients there, and absorb them. During this process, rice cellulose, a high molecular weight polysaccharide, is broken down by fungal enzymes (carbohydrases) into small fragments – oligosaccharides. After a certain period of cultivation, the mushroom material with fermentation products is centrifuged, concentrated and subjected to dry freezing. Then it is packaged in capsules. This information is googled, I am not a doctor and I do not understand this, who is interested there is a lot of information in all languages ..
My impressions after 1.5 months of taking 2 capsules per day (1500 mg).
I started taking this supplement during a sluggish flu, I can’t say that I was cured right away, it just took a long time, but I endured it on my feet.
In the reviews I read that many papillomavirus passes after taking AHCC. I don’t know for sure whether I have it or not, I didn’t do any tests, but there are several small ones on my body, they haven’t gone anywhere, well, maybe they’ve become a little less ..
In general, I drink in a prophylactic dose before the autumn-winter season. From what I can note, this is a good mood, i.e. there are mental improvements and no fatigue, although I sleep very little. Usually during the day I want to sleep terribly, besides I am a hippotonist. Now in this regard I feel like a man, despite the difficult, busy period, perhaps the drug affects the pressure. I believe in the usefulness of this complex and taking advantage of the discount, I will buy more .. The price is unfortunately high .. (The capsules themselves are of a standard size, they are swallowed easily. The instructions do not say, but there is a general recommendation to drink mushroom complexes with 1-2 glasses of water in 30-40 minutes before meals
AHCC instructions for use
AHCC recommended doses.
1. Disease prevention doses:
1000-3000mg AHCC or 2-6 capsules per day in three divided doses. Children for the purpose of prevention – 1 capsule 1 time per day.
2. Support in the treatment of cancer, prevention of side effects of anti-cancer therapy:
AHCC 3000-6000 mg or 6-12 capsules per day.
The Association for the Study of AHCC recommends that AHCC support the immune system in all cancers except blood disorders.
ANSS: indications
– Benign and malignant neoplasms.
– Immunodeficiency.
– Hepatitis B and C.
– Diabetes.
– Herpes.
– Skin viral diseases.
– Atopic dermatitis.
– Weakened immunity.
– Chronic fatigue syndrome.
– Urogenital infections.
The drug should not be taken in case of individual intolerance to at least one of the components, as well as in case of blood diseases.
AHCC is being investigated in the United States, China, Korea, Japan and Thailand.